Thursday, March 2, 2017

ID Practitioner - Hepatitis outlook: early February 2017

From the Journals
Publish date: March 2, 2017
By: Richard Pizzi

If you work on the front lines of medical care treating patients with hepatitis, you may not have time to review all the hepatitis research that enters the medical literature every month. Here’s a quick look at some notable news items and journal articles published over the past month, covering a variety of the major hepatitis viruses.

A study found that the combination of glecaprevir and pibrentasvir was highly efficacious and well-tolerated in patients with hepatitis C virus GT1 infection and prior failure to direct-acting antiviral-containing therapy; although ribavirin coadministration did not improve efficacy.

No comments:

Post a Comment